Inogen (INGN) Non-Current Assets (2013 - 2026)
Inogen (INGN) reported Non-Current Assets of $95.3 million for Q1 2026, down 11.55% year-over-year from $107.7 million in Q1 2025, and down 5.05% quarter-over-quarter from $100.3 million in Q4 2025.
Inogen (INGN) Non-Current Assets (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Non-Current Assets data on file, last reported at $95.3 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $95.3 million, down 11.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $407.8 million (down 8.6% YoY), and the FY2025 annual result was $100.3 million, down 9.4% from the prior year.
- Non-Current Assets fell to $95.3 million in Q1 2026 per INGN's latest filing, from $100.3 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $156.5 million in Q1 2022 and troughed at $95.3 million in Q1 2026.
- A 5-year average of $116.4 million and a median of $110.7 million in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets plunged 37.38% in 2022, then rose 18.66% in 2023.
- A 5-year view of Non-Current Assets shows it stood at $100.4 million in 2022, then increased by 18.66% to $119.1 million in 2023, then declined by 7.05% to $110.7 million in 2024, then declined by 9.4% to $100.3 million in 2025, then decreased by 5.05% to $95.3 million in 2026.
- Business Quant data shows INGN's Non-Current Assets at $95.3 million in Q1 2026, $100.3 million in Q4 2025, and $103.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.34 Bn |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | 95.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.26 Mn |
| Dec 31, 2025 | 100.33 Mn |
| Sep 30, 2025 | 103.29 Mn |
| Jun 30, 2025 | 108.92 Mn |
| Mar 31, 2025 | 107.70 Mn |
| Dec 31, 2024 | 110.73 Mn |
| Sep 30, 2024 | 113.62 Mn |
| Jun 30, 2024 | 114.13 Mn |
| Mar 31, 2024 | 116.41 Mn |
| Dec 31, 2023 | 119.13 Mn |
| Sep 30, 2023 | 118.43 Mn |
| Jun 30, 2023 | 105.13 Mn |
| Mar 31, 2023 | 102.53 Mn |
| Dec 31, 2022 | 100.40 Mn |
| Sep 30, 2022 | 151.81 Mn |
| Jun 30, 2022 | 154.62 Mn |
| Mar 31, 2022 | 156.49 Mn |
| Dec 31, 2021 | 160.33 Mn |
| Sep 30, 2021 | 177.03 Mn |
| Jun 30, 2021 | 170.61 Mn |